Related Experiment Video
Updated: Jul 16, 2026
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Immunosuppressive activity of 4-O-methylascochlorin
Mie Tsuruga1, Hiroo Nakajima, Junji Magae
1Department of Biotechnology, Institute of Research and Innovation (IRI), Kashiwa, Chiba 277-0861, Japan.
Abstract:
A major strategy for suppressing immune responses is the elimination of antigen-reactive lymphocytes through apoptosis. 4-O-Methylascochlorin (MAC) is a methylated derivative of a prenyl-phenol antibiotic, ascochlorin. MAC induces apoptosis in various lymphocyte cell lines. We found that MAC strongly suppressed killer T-cell activity induced by allogenic skin grafts. MAC did not suppress the killer T-cell activity induced by intraperitoneal injection of live allogenic tumor cells bearing both class I and II MHC. MAC suppressed IL-2 production of splenocytes from allogenic skin-implanted mice when induced by specific spleen adherent cells, but not by antibodies for T-cell receptor epsilon. These results suggest that MAC suppresses the antigen presentation process of alloantigen that is mediated by professional antigen presenting cells. MAC significantly increased the survival time of allogenic skin implanted on the flank mice. These results suggest that MAC may be clinically useful as an immunosuppressant that targets the antigen presentation process.
Insights
4-O-Methylascochlorin (MAC) suppresses immune responses by inducing lymphocyte apoptosis and inhibiting antigen presentation. This novel immunosuppressant shows promise for clinical applications by targeting antigen-presenting cells and prolonging graft survival.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Immune suppression is crucial for preventing transplant rejection.
- Inducing apoptosis in antigen-reactive lymphocytes is a key strategy.
- 4-O-Methylascochlorin (MAC), a derivative of ascochlorin, is explored for its immunomodulatory effects.
Purpose of the Study:
- To investigate the immunosuppressive mechanisms of 4-O-Methylascochlorin (MAC).
- To evaluate MAC's efficacy in suppressing immune responses against allografts.
- To determine if MAC targets antigen presentation pathways.
Main Methods:
- Assessing MAC's effect on lymphocyte apoptosis in vitro.
- Evaluating MAC's impact on killer T-cell activity induced by allografts and tumor cells.
- Measuring IL-2 production in splenocytes.
- Assessing the effect of MAC on allogenic skin graft survival time.
Main Results:
- MAC induces apoptosis in lymphocyte cell lines.
- MAC suppressed killer T-cell activity against skin grafts but not tumor cells.
- MAC inhibited IL-2 production by splenocytes when induced by specific spleen adherent cells.
- MAC significantly increased the survival time of allogenic skin grafts.
Conclusions:
- MAC suppresses immune responses primarily by inhibiting the antigen presentation process mediated by professional antigen-presenting cells.
- MAC's ability to induce lymphocyte apoptosis and target antigen presentation suggests potential clinical utility as an immunosuppressant.
- MAC demonstrates efficacy in prolonging allograft survival, highlighting its therapeutic potential.
